Predictors of response to mood stabilizers

Journal of Clinical Psychopharmacology

Volumn 16, Issue 2 SUPPL. 1, 1996, Pages

  Calabrese, Joseph R ^a   Fatemi, S Hossein ^a   Kujawa, Mary ^a   Woyshville, Mark J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; VALPROATE SEMISODIUM;

BIPOLAR DEPRESSION; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MOOD; PRIORITY JOURNAL; REVIEW;

EID: 0029987780     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199604001-00004     Document Type: Review

References (88)

1. Jefferson JW. Lithium. In: Goodnick PJ, ed. Predictors of treatment response in mood disorders. Washington DC: American Psychiatric Press, 1996;95-117.
2. Zis AP, Grof P, Webster M, Goodwin FK. Prediction of relapse in recurrent affective disorder. Psychopharmacol Bull 1980;16: 47-50.
3. Keller MB, Lavori PW, Kane JM, Gelenberg AJ, Rosenbaum JF, Walzer EA, Baker LA. Subsyndromal symptoms in bipolar disorder: a comparison of standard and low serum levels of lithium. Arch Gen Psychiatry 1992;49:371-6.
4. O'Connell RA, Mayo JA, Eug LK, Jones JS, Gabel RH. Social support and long term lithium outcome. Br J Psychiatry 1985;147: 272-5.
5. Winokur G, Coryell W, Keller M, Endicott J, Akiskal HA. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 1993;50:457-65.
6. Winokur G, Kadrmas A. A polyepisodic course in bipolar illness: possible clinical relationships. Compr Psychiatry 1989;30:121-7.
7. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a four-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990;47:1106-11.
8. Prien RF, Caffey EM Jr, Kiett J. Factors associated with treatment success in lithium carbonate prophylaxis: a report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1974;31:189-92.
9. Gaviria M, Flaherty J, Val E. A comparison of bipolar patients with and without a borderline personality disorder. Psychiatr J Univ Ott 1982;7:190-5.
10. Peselow ED, Dunner DL, Fieve RR, Lautin A. Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients. Am J Psychiatry 1982;139:747-52.
11. Grof P, Angst J, Karasek M, Keituer G. Patient selection for long-term lithium treatment in clinical practice. Arch Gen Psychiatry 1979;36:894-7.
12. Janicak PG, Newman RH, Davis JM. Advances in the treatment of mania related disorders: a reappraisal. Psychiatr Ann 1992;22: 92-103.
13. Kukopulos A, Reginaldi D, Laddomada P, Floric G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmacopsychiatry 1980;13:156-67.
14. Maj M, Pirozzi R, Starace F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J Affect Disord 1989;17:237-41.
15. Maj M, Del Vecchio M, Starace F, Pirozzi R, Kemali D. Prediction of affective psychoses response to lithium prophylaxis. Acta Psychiatr Scand 1984;69:37-44.
16. Grof P, Alda M, Grof E, Fox D, Cameron P. The challenge of predicting response to stabilizing lithium treatment: the importance of patient selection. Br J Psychiatry 1993;163:16-9.
17. Aagaard J, Vestergaard P. Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J Affect Disord 1990;18:259-66.
18. Abou-Saleh MT, Coppen AJ. Predictors of long-term outcome of mood disorders on prophylactic lithium. Lithium 1990;1:27-35.
19. Peselow ED, Sanfilipo MP, Fieve RR. Relationship between hypomania and personality disorders before and after successful treatment. Am J Psychiatry 1995;152:232-8.
20. Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, Warshaw M, Clayton P, Goodwin F. Switching from "unipolar" to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 1995;52: 114-23.
21. Abou-Saleh MT, Coppen A. Who responds to prophylactic lithium? J Affect Disord 1986;10:115-25.
22. Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ. Mixed states and bipolar rapid cycling and their treatment with divalproex sodium. Psychiatr Ann 1993;23:70-8.
23. Kraepelin E, ed. Manic-depressive insanity, paranoia. Edinburgh: ES Livingstone, 1921.
24. Rennie TAC. Prognosis in manic-depressive psychoses. Am J Psychiatry 1942;98:801-4.
25. Kotin J, Goodwin FK. Depression during mania: clinical observations and theoretical implications. Am J Psychiatry 1972;129: 55-62.
26. Carlson GA, Goodwin FK. The stage of mania: a longitudinal analysis of the manic episode. Arch Gen Psychiatry 1973;28: 221-8.
27. Himmelhoch JM, Mulla D, Neil JF, Detre TP, Kupfer DJ. Incidence and significance of mixed affective states in a bipolar population. Arch Gen Psychiatry 1976;33:1062-6.
28. Swann AC, Secunda SK, Katz MM, Koslow SH, Maas JW, Chang S, Robins E. Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res 1986;18:127-41.
29. Himmelhoch JM, Garfinkel ME. Mixed mania: diagnosis and treatment. Psychopharmacol Bull 1986;22:613-20.
30. Secunda SK, Swann A, Katz MM, Koslow SH, Croughan J, Chang S. Diagnosis and treatment of mixed mania. Am J Psychiatry 1987;144:96-8.
31. Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Correlates of antimanic response to carbamazepine. Psychiatry Res 1987;21:71-83.
32. Prien RF, Himmelhoch JM, Kupfer DJ. Treatment of mixed mania. J Affect Disord 1988;15:9-15.
33. Post RM, Rubinow DR, Uhde TW, Roy-Byrne PP, Linnoila M, Rosoff A, Cowdry R. Dysphoric mania: clinical and biological correlates. Arch Gen Psychiatry 1989;46:353-8.
34. Post RM. Non-lithium treatment for bipolar disorder. J Clin Psychiatry 1990;51[suppl 8]:9-16.
35. Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990;147:431-4.
36. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate, lithium in the treatment of acute mania. Am J Psychiatry 1992;149:108-11.
37. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino ES, Risch SC, Goodnick PJ, Morris DD, for the Depakote Mania Study Group. Efficacy of divalproex vs lithium, placebo in the treatment of mania. JAMA 1994;271:918-24.
38. Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ. Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol 1993;13:280-3.
39. Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974;30:229-33.
40. Bauer MS, Calabrese JR, Dunner DL, Post RP, Whybrow PC, Gyulai L, Tay LK. Multi-site data reanalysis: validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 1994;151:506-15.
41. Fawcett J, Scheftner W, Fogg L, Clark DC, Young MA, Hedeker D, Gibbons R. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990;147:1189-94.
42. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman BA. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995;152:1130-8.
43. Coryell W, Endicott J, Keller M. Rapid cycling affective disorder: demographics, diagnosis, family, and course. Arch Gen Psychiatry 1992;49:126-31.
44. Okuma T. Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 1993;27:138-45.
45. Ketter TA, Pazzaglia PJ, Post RM. Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature. J Clin Psychopharmacol 1992;12:276-81.
46. Keck PE, McElroy SL, Vuckovic A, Friedman L. Combined valproate and carbamazepine treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:319-22.
47. Di Costanzo E, Schifano F. Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder. Acta Psychiatr Scand 1991;83:456-9.
48. Stuppaeck C, Barnas C, Miller C, Schwitzer J, Fleischhacker WW. Carbamazepine in the prophylaxis of mood disorders. J Clin Psychopharmacol 1990;10:39-42.
49. Kramlinger KG, Post RM. Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatr Scand 1989;79:378-85.
50. Joyce PR. Carbamazepine in rapid-cycling bipolar affective disorder. Int Clin Psychopharmacol 1988;3:123-9.
51. Lerer B, Moore N, Meyendorff E, Cho S-R, Gershon S. Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987;48:89-93.
52. Laird LK, Knox EP. The use of carbamazepine and lithium in controlling a case of chronic rapid cycling. Pharmacotherapy 1987;7: 130-2.
53. Levy JM, Remick RA. Clinical aspects and treatment of rapid cycling mood disorders. Can J Psychiatry 1986;31:436-41.
54. Lovett L, Watkins SE, Shaw DM. The use of alternative drug therapy in nine patients with recurrent affective disorder resistant to conventional prophylaxis. Biol Psychiatry 1986;21:1344-7.
55. Stromgren LS, Boller S. Carbamazepine in treatment and prophylaxis of manic-depressive disorder. Psychiatr Dev 1985;4:349-67.
56. Shukla S, Cook BL, Miller MG. Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness. J Affect Disord 1985;147:219-22.
57. Elphick M. An open clinical trial of carbamazepine in treatment-resistant bipolar and schizoaffective psychotics. Br J Psychiatry 1985;147:198-200.
58. Post RM, Berrettini W, Uhde T, Kellner C. Selective response to the anticonvulsant carbamazepine in manic depressive illness: a case study. J Clin Psychopharmacol 1984;4:178-85.
59. Greil W, Kruger R, Robnagl G, Schertel M, Walther A. Prophylactic therapy of affective disorders with carbamazepine: an open clinical trial. In: Emrich HM, Okuma T, Muller AA, eds. Anticonvulsants in affective disorders. Amsterdam: Excerpta Med Int Congr Ser, 1984:153-9.
60. Kanter GL, Yerevanian BI, Ciccone JR. Case report of a possible interaction between neuroleptics and carbamazepine. Am J Psychiatry 1984;141:1101-2.
61. Kwamie Y, Persad E, Stancer H. The use of carbamazepine as an adjunctive medication in the treatment of affective disorders: a clinical report. Can J Psychiatry 1984;29:605-8.
62. Del Zompo M, Burrai C, Piccardi MP, Marelli A, Corsini GU. Prophylactic efficacy of carbamazepine in lithium-resistant affective disorders. In: Corsini GU, ed. Current trends in lithium and rubidium therapy. Lancaster, PA: MTP Press, 1983:325-30.
63. Post RM, Uhde TW, Ballenger JC, Sauillace KM. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry 1983;140:1602-4.
64. Nolen WA. Carbamazepine: a possible adjunct or alternative to lithium in bipolar disorder. Acta Psychiatr Scand 1983;67:218-25.
65. Kishimoto A, Ogura C, Hazama H, Inouse K. Long-term prophylactic effects of carbamazepine in affective disorder. Br J Psychiatry 1983;143:327-31.
66. Inoue K, Arima S, Tanaka K, Fukui Y, Kato N. A lithium and carbamazepine combination in the treatment of bipolar disorder: a preliminary report. Folia Psychiatr Neurol Jpn 1981;35:465-76.
67. Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A. Antimanic, prophylactic effects of carbamazepine (Tegretol) on manic-depressive psychosis: a preliminary report. Folia Psychiatr Neurol Jpn 1973;27:283-97.
68. Calabrese JR, Bowden C, Woyshville MJ. Lithium and anticonvulsants in bipolar disorder. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1994:1099-111.
69. Post RM, Leverich GS, Rosoff AS, Altshuler LL. Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term follow-up. J Clin Psychopharmacol 1990;10:318-27.
70. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. JAMA 1990;264:2511-8.
71. Schweizer E, Rickels K, Case WG, Greenblatt DJ. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome. Arch Gen Psychiatry 1991;48:448-52.
72. Weiss SRB, Post RM, Aigner TG. Potential utility of the anticonvulsant carbamazepine in the treatment of cocaine-induced disorders: clinical and mechanistic implications. In: Watson RK, ed. Alcohol and drug abuse reviews: treatment of drug and alcohol abuse. Clifton, NJ: Humana Press, 1992;149-74.
73. Himmelhoch JM. Mixed states, manic-depressive illness, and the nature of mood. Psychiatr Clin North Am 1979;2:449-59.
74. Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 1985;42:1050-5.
75. Schuckit MA. Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry 1986;143:140-7.
76. Buydens-Branchey L, Branchey MH, Noumair D. Age of alcoholism onset: I. relationship to psychopathology. Arch Gen Psychiatry 1989;46:225-30.
77. Helzer JE, Winokur G. A family interview study of male manic depressives. Arch Gen Psychiatry 1974;31:73-7.
78. Dunner DL, Gershon ES, Goodwin FK. Heritable factors in the severity of affective illness. Biol Psychiatry 1976;11:31-42.
79. Morrison JR. The family histories of manic-depressive patients with and without alcoholism. J Nerv Ment Dis 1975;160:227-9.
80. Freed EX. Alcohol abuse by manic patients. Psychol Rep 1969; 25:280.
81. Lewis CE, Helzer J, Cloninger CR, Croughan J, Whitman BY. Psychiatric diagnostic predisposition to alcoholism. Compr Psychiatry 1982;23:451-61.
82. Estroff TW, Dackis CA, Gold MS, Pottash ALC. Drug abuse and bipolar disorders. Int J Psychiatry Med 1985;15:37-40.
83. Weissman MM, Myers JK. Clinical depression in alcoholism. Am J Psychiatry 1980;137:372-3.
84. Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JDJ, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949-58.
85. Regier DA, Boyd JH, Burke JD, Rae DS, Myers JK, Kramer M, Robins LN, George LK, Karno M, Locke BZ. One-month prevalence of mental disorders in the United States: based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry 1988;45:977-86.
86. Hensel B, Dunner DL, Fieve RR. The relationship of family history of alcoholism to primary affective disorder. J Affect Disord 1979;1:105-13.
87. Dunner DL, Hensel BM, Fieve RR. Bipolar illness: factors in drinking behavior. Am J Psychiatry 1979;136:583-5.
88. Endicott J, Nee J, Andreasen N, Clayton P, Keller M, Coryell W. Bipolar II: combine or keep separate? J Affect Disord 1985;8:17-28.